Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 52,000 KRW
Change Today -6,700.00 / -11.41%
Volume 835.1K
096530 On Other Exchanges
Symbol
Exchange
KOSDAQ
As of 2:29 AM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for seegene inc (096530)

Although debt as a percent of total capital decreased at Seegene, Inc. over the last fiscal year to 24.45%, it is still in-line with the Biotechnology industry's norm. Additionally, there are enough liquid assets to satisfy current obligations. Cash Collection is a strong suit as the company is more effective than most in the industry. As of the end of 2014, its uncollected receivables totaled 50.1B KRW, which, at the current sales rate provides a Days Receivables Outstanding of 274.45. Last, inventories seem to be well managed as the Inventory Processing Period is typical for the industry, at 218.63 days.
View Balance Sheet In U.S. Dollar
Currency in
Millions of South Korean Wons
As of:Dec 31
2011
Press
Release

KRW
Dec 31
2012
Press
Release

KRW
Dec 31
2013
KRW
Dec 31
2014
KRW
4 Year
Trend
Assets    
Cash and Equivalents18,372.64,306.125,961.819,530.6
Short-Term Investments15,936.98,133.79,000.09,086.7
Trading Asset Securities----995.22,513.0
TOTAL CASH AND SHORT TERM INVESTMENTS34,309.612,439.835,957.031,130.4
Accounts Receivable24,351.233,161.546,810.950,051.8
Notes Receivable----873.8--
Other Receivables----961.0520.4
TOTAL RECEIVABLES24,351.233,161.548,645.750,572.2
Inventory2,670.64,727.38,842.412,219.4
Prepaid Expenses----102.7318.8
Other Current Assets1,556.72,290.02,056.43,002.5
TOTAL CURRENT ASSETS62,888.152,618.695,604.197,243.4
Gross Property Plant and Equipment----8,865.619,074.5
Accumulated Depreciation-----4,235.0-9,116.6
NET PROPERTY PLANT AND EQUIPMENT2,809.24,479.14,630.69,957.9
Goodwill------1,253.2
Long-Term Investments2,000.02,618.81,609.81,634.0
Accounts Receivable, Long Term4,048.28,971.02,347.7755.4
Loans Receivable, Long Term----1,169.61,457.7
Deferred Tax Assets, Long Term768.81,854.81,662.32,872.7
Deferred Charges, Long Term----14,632.716,400.9
Other Intangibles5,973.613,073.4875.3903.3
Other Long-Term Assets----6,506.95,974.9
TOTAL ASSETS78,487.883,615.6129,039.0138,453.3
    
LIABILITIES & EQUITY    
Accounts Payable4,534.35,068.64,267.04,122.8
Accrued Expenses----635.9865.9
Short-Term Borrowings----4,000.04,057.9
Current Portion of Long-Term Debt/Capital Lease----3,270.8118.3
Current Income Taxes Payable1,034.42,077.92,284.41,070.1
Other Current Liabilities, Total569.6168.9803.52,219.3
TOTAL CURRENT LIABILITIES6,138.27,315.415,261.712,454.3
Long-Term Debt30,194.031,422.825,312.926,521.0
Minority Interest------84.8
Pension & Other Post-Retirement Benefits1,423.42,827.23,874.44,527.4
Other Non-Current Liabilities--113.0144.8115.7
TOTAL LIABILITIES37,755.541,678.444,593.843,618.4
Common Stock6,536.36,548.18,426.212,652.6
Additional Paid in Capital23,158.023,169.754,142.451,932.4
Retained Earnings10,889.119,516.529,130.138,395.6
Treasury Stock-----8,173.9-8,224.2
Comprehensive Income and Other148.9-7,297.0920.3-6.4
TOTAL COMMON EQUITY40,732.341,937.284,445.294,750.1
TOTAL EQUITY40,732.341,937.284,445.294,834.9
TOTAL LIABILITIES AND EQUITY78,487.883,615.6129,039.0138,453.3
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
096530:KS 52,000.00 KRW -6,700.00

096530 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cepheid $56.02 USD +0.43
GenMark Diagnostics Inc $8.33 USD -0.17
Luminex Corp $17.31 USD +0.08
QIAGEN NV €25.69 EUR +0.299
Sequenom Inc $2.82 USD 0.00
View Industry Companies
 

Industry Analysis

096530

Industry Average

Valuation 096530 Industry Range
Price/Earnings 100.0x
Price/Sales 22.0x
Price/Book 14.6x
Price/Cash Flow 113.8x
TEV/Sales 21.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SEEGENE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.